Cortech Revenue and Competitors
Estimated Revenue & Valuation
- Cortech's estimated annual revenue is currently $5.9M per year.
- Cortech's estimated revenue per employee is $108,000
Employee Data
- Cortech has 55 Employees.
- Cortech grew their employee count by 4% last year.
Cortech's People
Name | Title | Email/Phone |
---|
Cortech Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.5M | 51 | 31% | N/A | N/A |
#2 | $1.3M | 18 | -5% | N/A | N/A |
#3 | $0.2M | 4 | 0% | N/A | N/A |
#4 | $6.9M | 64 | 78% | N/A | N/A |
#5 | $6.9M | 64 | 25% | N/A | N/A |
#6 | $9.7M | 81 | -1% | N/A | N/A |
#7 | $5.6M | 52 | 0% | N/A | N/A |
#8 | $3.9M | 41 | -2% | N/A | N/A |
#9 | $3.2M | 33 | -8% | N/A | N/A |
#10 | $7M | 65 | 3% | N/A | N/A |
What Is Cortech?
Cortech, Inc. is a biopharmaceutical company whose primary focus was the discovery and development of novel therapeutics for the treatment of inflammatory disorders. Specifically, Cortech directed its research and development efforts toward protease inhibitors and bradykinin antagonists. In response to disappointing test results and its loss of collaborative partner support, Cortech implemented a series of reductions in force and effectively discontinued all internal research and development activities. Cortech no longer has the staff or operative facilities required to recommence internal research and development activities. Its strategy is to seek collaborative partners to conduct and fund its future research and development or to sell the rights to certain of the compounds in its portfolio to third parties. At the same time, Cortech is seeking to redeploy its assets into an operating business.
keywords:N/AN/A
Total Funding
55
Number of Employees
$5.9M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.8M | 55 | 0% | N/A |
#2 | $7.4M | 55 | -14% | N/A |
#3 | $10.9M | 55 | 77% | N/A |
#4 | $35M | 55 | 8% | N/A |
#5 | $6.2M | 55 | -2% | $36.4M |